-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$28.00367.45% Upside
Lexeo Therapeutics, Inc. Common Stock Frequently Asked Questions
-
What analysts cover Lexeo Therapeutics, Inc. Common Stock?
Lexeo Therapeutics, Inc. Common Stock has been rated by research analysts at Robert W. Baird in the past 90 days.